F-group (family)
316.1.1.2 NTP_transf_2
Ligands and drugs
630
Member domains
95
with ligand contacts (≤ 4 Å)
15.1% of members
80
with DrugDomain annotations
12.7% of members
70
with a DrugBank compound
11.1% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 316.1.1.2 belongs to X-group 316 Nucleotidyltransferase-like, which binds 7.3 ligand superclasses per 20 proteins, narrower than 56% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02431 | CTP | Cytidine-5'-Triphosphate | 16 |
| DB02596 | APC | alpha,beta-Methyleneadenosine 5'-triphosphate | 12 |
| DB00171 | ATP | ATP | 11 |
| DB00452 | NMY | Framycetin | 3 |
| DB00919 | SCM | Spectinomycin | 3 |
| DB04005 | UTP | Uridine 5'-triphosphate | 3 |
| DB00684 | TOY | Tobramycin | 2 |
| DB04160 | PPV | Pyrophosphoric acid | 2 |
| DB00131 | AMP | Adenosine phosphate | 1 |
| DB02987 | — | — | 1 |
| DB03222 | DTP | dATP | 1 |
| DB03685 | U5P | Uridine monophosphate | 1 |
| DB09459 | TLA | L-tartaric acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 44 |
| CTP | CYTIDINE-5'-TRIPHOSPHATE | 17 |
| APC | DIPHOSPHOMETHYLPHOSPHONIC ACID ADENOSYL ESTER | 12 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 12 |
| MNmetal | MANGANESE (II) ION | 7 |
| NMY | NEOMYCIN | 6 |
| CL | CHLORIDE ION | 5 |
| POP | PYROPHOSPHATE 2- | 4 |
| UTP | URIDINE 5'-TRIPHOSPHATE | 4 |
| 2KH | 5'-O-[(S)-hydroxy{[(S)-hydroxy(phosphonooxy)phosphoryl]amino}phosphoryl]uridine | 3 |
| CAmetal | CALCIUM ION | 3 |
| SCM | SPECTINOMYCIN | 3 |
| AMP | ADENOSINE MONOPHOSPHATE | 2 |
| PPV | PYROPHOSPHATE | 2 |
| TOY | TOBRAMYCIN | 2 |
| ZNmetal | ZINC ION | 2 |
| DTP | 2'-DEOXYADENOSINE 5'-TRIPHOSPHATE | 1 |
| IOD | IODIDE ION | 1 |
| NE0 | [[(2R,3R,4R,5R)-5-[2,4-bis(oxidanylidene)pyrimidin-1-yl]-3-oxidanyl-4-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate | 1 |
| TLA | L(+)-TARTARIC ACID | 1 |